Key Considerations for Advanced Therapies Manufacturing

This webcast features: Thomas Page, PhD, Vice President, Engineering and Asset Development, Fujifilm Diosynth Biotechnologies

This technical webinar covers key considerations to support manufacturing activities from the earliest stages of cell line, viral replication platforms and/or viral vectors identification stage leading into clinical production. Having a line of sight into commercial production and the requirements leading into commercial approval are also essential for success.

Key messages:

  • Flexibility in conjunction with high containment are key for success
  • Application of closed systems in designing the manufacturing process including fill/finish
  • Facilities to support advanced therapy manufacturing should be treated as pieces of equipment